Lincoln Pharmaceuticals Ltd (LPL) on Wednesday launched the capsule version of Tinnex as a cure for tinnitus (ringing sensation in the ear), as the next step of the launch of this drug.
The success rate of cure of patients using Tinnex is 61 per cent, an official said here.
The Ahmedabad-based listed company, having a turnover of Rs 130 crore in 2010-11, had developed Tinnex following an agreement with Phafag AG, Switzerland, for its Caroverine molecule, Mr Mahendra G. Patel, Managing Director, said.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.